Royal Bank of Canada’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35K | Sell |
3,663
-26,238
| -88% | -$248K | ﹤0.01% | 5985 |
|
|
2026
Q1 | $281K | Buy |
29,901
+13,401
| +81% | +$113K | ﹤0.01% | 4504 |
|
|
2025
Q4 | $135K | Buy |
16,500
+1,247
| +8% | +$15.4K | ﹤0.01% | 5027 |
|
|
2025
Q3 | $193K | Buy |
15,253
+6,118
| +67% | +$58.2K | ﹤0.01% | 5108 |
|
|
2025
Q2 | $62K | Buy |
9,135
+2,716
| +42% | +$19.7K | ﹤0.01% | 5824 |
|
|
2025
Q1 | $34K | Sell |
6,419
-25,221
| -80% | -$223K | ﹤0.01% | 5715 |
|
|
2024
Q4 | $374K | Buy |
31,640
+26,232
| +485% | +$440K | ﹤0.01% | 4304 |
|
|
2024
Q3 | $112K | Buy |
5,408
+4,219
| +355% | +$216K | ﹤0.01% | 5263 |
|
|
2024
Q2 | $54K | Sell |
1,189
-3,991
| -77% | -$168K | ﹤0.01% | 5607 |
|
|
2024
Q1 | $203K | Sell |
5,180
-16,918
| -77% | -$417K | ﹤0.01% | 4677 |
|
|
2023
Q4 | $134K | Buy |
22,098
+20,780
| +1,577% | +$112K | ﹤0.01% | 5421 |
|
|
2023
Q3 | $9K | Sell |
1,318
-194
| -13% | -$1.34K | ﹤0.01% | 6442 |
|
|
2023
Q2 | $12K | Buy |
+1,512
| New | +$13.6K | ﹤0.01% | 6406 |
|
|
2023
Q1 | – | Sell |
-1,090
| Closed | -$4K | – | 7126 |
|
|
2022
Q4 | $4K | Buy |
1,090
+53
| +5% | +$204 | ﹤0.01% | 6779 |
|
|
2022
Q3 | $5K | Buy |
1,037
+1,034
| +34,467% | +$7.29K | ﹤0.01% | 6719 |
|
|
2022
Q2 | $0 | Sell |
3
-540
| -99% | -$5.22K | ﹤0.01% | 7411 |
|
|
2022
Q1 | $8K | Buy |
543
+315
| +138% | +$4.17K | ﹤0.01% | 7043 |
|
|
2021
Q4 | $4K | Sell |
228
-192
| -46% | -$5.2K | ﹤0.01% | 7265 |
|
|
2021
Q3 | $13K | Sell |
420
-883
| -68% | -$34.8K | ﹤0.01% | 6864 |
|
|
2021
Q2 | $71K | Sell |
1,303
-1,486
| -53% | -$82.5K | ﹤0.01% | 5802 |
|
|
2021
Q1 | $164K | Buy |
2,789
+1,242
| +80% | +$81.6K | ﹤0.01% | 5098 |
|
|
2020
Q4 | $58K | Sell |
1,547
-2,551
| -62% | -$95.4K | ﹤0.01% | 5604 |
|
|
2020
Q3 | $222K | Sell |
4,098
-520
| -11% | -$94.2K | ﹤0.01% | 4471 |
|
|
2020
Q2 | $1.16M | Sell |
4,618
-1,407
| -23% | -$284K | ﹤0.01% | 3046 |
|
|
2020
Q1 | $947K | Buy |
6,025
+828
| +16% | +$140K | ﹤0.01% | 3076 |
|
|
2019
Q4 | $851K | Sell |
5,197
-548
| -10% | -$81K | ﹤0.01% | 3573 |
|
|
2019
Q3 | $839K | Buy |
5,745
+451
| +9% | +$78.6K | ﹤0.01% | 3486 |
|
|
2019
Q2 | $1.1M | Sell |
5,294
-81
| -2% | -$17.3K | ﹤0.01% | 3225 |
|
|
2019
Q1 | $1.12M | Buy |
5,375
+1,050
| +24% | +$232K | ﹤0.01% | 3115 |
|
|
2018
Q4 | $758K | Sell |
4,325
-168
| -4% | -$33.5K | ﹤0.01% | 3381 |
|
|
2018
Q3 | $1.02M | Buy |
4,493
+434
| +11% | +$70.2K | ﹤0.01% | 3345 |
|
|
2018
Q2 | $615K | Buy |
4,059
+2,327
| +134% | +$423K | ﹤0.01% | 3631 |
|
|
2018
Q1 | $317K | Buy |
1,732
+1,671
| +2,739% | +$375K | ﹤0.01% | 4017 |
|
|
2017
Q4 | $13K | Sell |
61
-108
| -64% | -$23.1K | ﹤0.01% | 5767 |
|
|
2017
Q3 | $37K | Buy |
169
+128
| +312% | +$25K | ﹤0.01% | 5591 |
|
|
2017
Q2 | $8K | Buy |
41
+1
| +3% | +$196 | ﹤0.01% | 5877 |
|
|
2017
Q1 | $10K | Hold |
40
| – | – | ﹤0.01% | 5960 |
|
|
2016
Q4 | $10K | Buy |
40
+7
| +21% | +$1.6K | ﹤0.01% | 6075 |
|
|
2016
Q3 | $7K | Buy |
+33
| New | +$4.11K | ﹤0.01% | 5882 |
|
|
2015
Q3 | – | Sell |
-17
| Closed | -$2K | – | 6654 |
|
|
2015
Q2 | $2K | Buy |
+17
| New | +$1.71K | ﹤0.01% | 6363 |
|
Other funds holding CRBP
CAM
O
JHC
PM
SCM
ACM
Royal Bank of Canada's CRBP Position: Q2 2026 in Review
Royal Bank of Canada reduced its Corbus Pharmaceuticals (CRBP) stake by 88% in Q2 2026, selling an estimated $248K and leaving 3,663 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #5985.
Royal Bank of Canada first reported a position in CRBP in Q2 2015 and has held it in 40 quarters since. The position peaked at $1.16M in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.
- Royal Bank of Canada held 3,663 shares of Corbus Pharmaceuticals worth $35K as of Q2 2026.
- Royal Bank of Canada sold 26,238 Corbus Pharmaceuticals shares in Q2 2026, an estimated $248K.
- Corbus Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5985 holding.
- Royal Bank of Canada first reported a position in Corbus Pharmaceuticals in Q2 2015 and has held it in 40 quarters since.
- Royal Bank of Canada's Corbus Pharmaceuticals position peaked at $1.16M in Q2 2020.
- 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.